User profiles for James Mason

James Mason

- Verified email at warwick.ac.uk - Cited by 33693

James Mason

- Verified email at solarplan.org - Cited by 1826

β Blockade after myocardial infarction: systematic review and meta regression analysis

N Freemantle, J Cleland, P Young, J Mason, J Harrison - Bmj, 1999 - bmj.com
Objectives: To assess the effectiveness of β blockers in short term treatment for acute
myocardial infarction and in longer term secondary prevention; to examine predictive factors that …

The rsna-asnr-miccai brats 2021 benchmark on brain tumor segmentation and radiogenomic classification

…, RY Shih, L Siakallis, Y Bronstein, JR Mason… - arXiv preprint arXiv …, 2021 - arxiv.org
The BraTS 2021 challenge celebrates its 10th anniversary and is jointly organized by the
Radiological Society of North America (RSNA), the American Society of Neuroradiology (ASNR…

Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials

HO Dickinson, JM Mason, DJ Nicolson… - Journal of …, 2006 - journals.lww.com
Results We categorized trials by type of intervention and used random effects meta-analysis
to combine mean differences between endpoint blood pressure in treatment and control …

[HTML][HTML] Disabling immune tolerance by programmed death-1 blockade with pidilizumab after autologous hematopoietic stem-cell transplantation for diffuse large B …

…, HK Holland, JN Winter, JR Mason… - Journal of clinical …, 2013 - ncbi.nlm.nih.gov
Purpose The Programmed Death-1 (PD-1) immune checkpoint pathway may be usurped by
tumors, including diffuse large B-cell lymphoma (DLBCL), to evade immune surveillance. …

The technical, geographical, and economic feasibility for solar energy to supply the energy needs of the US

V Fthenakis, JE Mason, K Zweibel - Energy policy, 2009 - Elsevier
So far, solar energy has been viewed as only a minor contributor in the energy mixture of the
US due to cost and intermittency constraints. However, recent drastic cost reductions in the …

[HTML][HTML] Systems for grading the quality of evidence and the strength of recommendations II: pilot study of a new system

…, R Jaeschke, A Liberati, N Magrini, J Mason… - BMC health services …, 2005 - Springer
Background Systems that are used by different organisations to grade the quality of evidence
and the strength of recommendations vary. They have different strengths and weaknesses. …

Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia

P Moayyedi, S Soo, J Deeks, D Forman, J Mason… - Bmj, 2000 - bmj.com
Objectives: To evaluate efficacy and cost effectiveness of Helicobacter pylori eradication
treatment in patients with non-ulcer dyspepsia infected with H pylori. Design: Systematic review …

CTLA4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic cell transplantation

…, LE Morris, HK Holland, JR Mason… - Blood, The Journal …, 2009 - ashpublications.org
Relapse of malignancy after allogeneic hematopoietic cell transplantation (allo-HCT)
remains a therapeutic challenge. Blockade of the CTLA4 molecule can effectively augment …

Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability.

…, A House, P Watson, A Long, J Mason - British Medical …, 1993 - bmj.com
OBJECTIVE--To examine the evidence for using selective serotonin reuptake inhibitors
instead of tricyclic antidepressants in the first line treatment of depression. DESIGN--Meta-…

Topical treatments for chronic plaque psoriasis

AR Mason, J Mason, M Cork, G Dooley… - Cochrane Database …, 2013 - cochranelibrary.com
Background Chronic plaque psoriasis is the most common type of psoriasis, and it is
characterised by redness, thickness, and scaling. First‐line management of chronic plaque …